StockData
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Stereotaxis, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.01+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$101.03M
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Nov 11, 2026, before market open (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 11, 2026During market hours$7.70M$-0.05–
Q1 FY2026
Ended Mar 31, 2026
May 12, 2026During market hours$6.30M$-0.06–
Q4 FY2025
Ended Dec 31, 2025
Mar 9, 2026During market hours$8.60M$-0.06–
Q3 FY2025
Ended Sep 30, 2025
Nov 12, 2025Before market open$7.50M$-0.07–
Q2 FY2025
Ended Jun 30, 2025
Aug 7, 2025During market hours$8.80M$-0.05–
Q1 FY2025
Ended Mar 31, 2025
May 12, 2025During market hours$7.50M$-0.07–
Q4 FY2024
Ended Dec 31, 2024
Mar 3, 2025Before market open$6.30M$-0.09–
Q3 FY2024
Ended Sep 30, 2024
Nov 12, 2024Before market open$9.20M––
Q2 FY2024
Ended Jun 30, 2024
Aug 12, 2024During market hours–––
Q1 FY2024
Ended Mar 31, 2024
May 13, 2024During market hours–––
Q4 FY2023
Ended Dec 31, 2023
Mar 4, 2024During market hours–––

Company guidance

Outlook given with results on Aug 11, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
recurring revenuethird quarter$7.00MLowered
System revenuethird quarter$3.00MLowered
recurring revenuefourth quarter$8.00MLowered
System revenuefourth quarter$3.00MLowered

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Stereotaxis filed with the SEC